NACB Announces 2013 Award Winners

NACB is pleased to announce that the following recipients have received the 2012 NACB awards. Con​gratulations to this year's award winners!

Professor Alvin Dubin Award for Outstanding Contributions to the Profession and the Academy


Shirley Welch, PhD, DABCC, FACB 

Dr. Shirley Welch, Ph D, DABCC, FACB recently retired after more than 20 years as the Director of Chemistry and Toxicology at Kaiser Permanente in Portland, OR and Adjunct Assistant Professor in the Pathology Department at Oregon Health and Sciences University.  She received her PhD in Biochemistry from the University of California, Berkeley and received a clinical chemistry fellowship at the Oregon Health Sciences University.  She joined the American Association for Clinical Chemistry in 1980 and the National Academy of Clinical Biochemistry in 1997.
Dr. Welch has been active in AACC at both the local and national levels.  She served on several committees including the Program Planning Commission and the Forensic Urine Drug Testing Laboratory Improvement Program Committee.   Dr. Welch was on the AACC Board of Directors from 1998-2001 and was Chair of the Annual Meeting Organizing Committee in 2004.   From 1997-2003, she was on the American Board of Clinical Chemistry, serving as Vice President and Chair of Examinations.
Dr. Welch served on NACB Education and Scientific Affairs Committee from 2006-2009 and was chair in 2009.  She remained on this committee when the NACB and AACC joined forces to form the AACC Evidence Based Laboratory Medicine Committee.  Most recently Dr. Welch served on and chaired the NACB Nominating Committee.

George Grannis Award for Excellence in Research and Scientific Publication 


Dina Greene, PhD, DABCC, FACB

Dr. Dina Greene embarked on her scientific career in Gainesville, Florida by obtaining a degree in Microbiology from the University of Florida.  As an undergraduate she distinctly remembers falling in love with biochemistry when she enrolled in the class "The Physiology and Biochemistry of Prokaryotes", where she immediately understood that some of her happiest moments would be spent deciphering complicated scientific phenomena.  Dr Greene then obtained her Ph.D. in Biochemistry at Emory University and subsequently migrated west, trading in her southern roots for snow-filled mountains, to complete the Clinical Chemistry Fellowship Program at the University of Utah.  In 2011 Dr Greene joined the staff at Northern California Kaiser Permanente, where she is enthusiastic about the diverse population served and contributions she can make toward positively impacting the quality of laboratory testing and results. Throughout her scientific career, Dr Greene has had the opportunity to work with amazing mentors and to establish numerous collaborations.  She undoubtedly understands that these relationships have acted as catalysts for her to achieve a successful publication record and scientific honors.

AACC/NACB Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research


Gregory Tsongalis, PhD, DABCC, FACB

Dr. Tsongalis is the director of the Molecular Pathology Laboratory and co-director of the Translational Research Program in the Geisel School of Medicine at Dartmouth, the Dartmouth Hitchcock Medical Center, and the Norris Cotton Cancer Center in Lebanon, NH. In 1994, he completed his post-doctoral training in clinical chemistry at the University of North Carolina, Chapel Hill where he was first exposed to molecular diagnostics. Throughout his career, Dr. Tsongalis has been striving to apply molecular techniques to diagnostic questions that are not adequately addressed by traditional lab methods and has challenged the boundaries between clinical pathology and anatomic pathology. His early work described methods for localized in situ amplification (LISA) of DNA and RNA targets in tissue sections as well as the identification of double heterozygotes in BRCA1 and BRCA2 mutation carriers. He described some of the first applications of molecular methods used in identity testing of clinical specimens when a mislabeling or mix-up was suspected. His laboratory embraced early automation for high volume molecular infectious disease testing and the development of molecular techniques for use with unconventional specimen types. His laboratory is currently applying state of the art molecular techniques to better patient management thru precision medicine. As a continuous challenge, his laboratory pushes the application of molecular technologies beyond their traditional uses and is now focusing on nanotechnologies for routine use in the clinical setting. His work has led to 140 publications and 8 textbooks in the field of Molecular Pathology. Dr. Tsongalis has served on numerous professional society committees including the AACC Board of Directors and the editorial boards of several medical journals including Clinical Chemistry.

Page Access: